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What is already known 
 Survival following birth before 26 weeks of gestation has increased steadily since 1995 in the 
UK   
 It is unclear whether long term outcomes have changed. 
 Between 1995 and 2006, survival without impairment had increased and estimated 
developmental test scores had improved at 3 years of age 
What this study adds 
 At 11 years of age in two national cohorts, the prevalence of neurodevelopmental impairment 
was unchanged  
 Mean test scores for IQ and academic attainment were similar in both cohorts 







Objective To determine whether improvements in school age outcomes had occurred between two 
cohorts of births at 22 to 25 weeks of gestation to women resident in England in 1995 and 2006. 
Design Longitudinal national cohort studies. 
Setting School or home-based assessments at 11 years of age. 
Participants EPICure2 cohort of births at 22-26 weeks of gestation in England during 2006: a sample 
of 200 of 1031 survivors were evaluated; outcomes for 112 children born at 22-25 weeks’ gestation 
were compared to those of 176 born in England during 1995 from the EPICure cohort. Classroom 
controls for each group acted as a reference population.  
Main outcome measures Standardised measures of cognition and academic attainment were 
combined with parent report of other impairments to estimate overall neurodevelopmental status. 
Results At 11 years in EPICure2, 18% had severe and 20% moderate impairments. Comparing births 
at 22-25 weeks in EPICure2 (n=112), 26% had severe and 21% moderate impairment compared to 
18% and 32% respectively in EPICure. After adjustment, the odds ratio of moderate or severe 
neurodevelopmental impairment in 2006 compared to 1995 was 0.76, 95%CI 0.45, 1.31; p=.32. IQ 
scores were similar in 1995 (mean 82.7; SD 18.4) and 2006 (81.4; SD 19.2), adjusted difference in 
mean z-scores 0.2SD (95%CI -0.2, 0.6), as were attainment test scores. The use of multiple 
imputation did not alter these findings. 
Conclusion Improvements in care and survival between 1995 and 2006 are not paralleled by 
improved cognitive or educational outcomes or a reduced rate of neurodevelopmental impairment.  
(words 250/250)  
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Survival for babies born at extremely low gestational ages is continually increasing in the UK1 and in 
many other countries.2 3 Allied with this there is an expectation that long term outcomes will begin 
to improve. In our analysis of outcomes at 3 years of age for births <25 weeks of gestation in 
England, we identified that between 1995 and 2006 there was an increase in survival without 
impairment for liveborn babies and an 8-point (0.5 standard deviation) increase in developmental 
test scores, although the rates of severe impairments were unchanged.4 Recent studies indicate that 
the prevalence of impaired outcomes in both early5 and middle childhood6 remains unchanged, and 
that educational and cognitive outcomes may even have deteriorated for extremely 
preterm/extremely low birthweight children born in 2005 compared with those born in the 1990s, 
despite improved survival.6 7 Meta-analyses also indicate no improvement in cognitive outcomes for 
children born very preterm despite increasing survival.8  
Predicting outcomes from infancy to middle childhood both in terms of categories of impairment9 
and absolute scores10 remains relatively poor but is better from early school age11 12, underscoring 
the need for longer term assessment. In light of the suggestion of improved outcomes in our 
population at 3 years4, we report neurodevelopmental and educational outcomes at 11 years for a 
sample of extremely preterm (EP) births in England during 2006 (the EPICure2 Study) and compare 
the prevalence of impairments between this group and those of the original EPICure Study of EP 
births in 1995.13 Based on the findings of our 3-year assessment, we hypothesized that we might see 




Population The EPICure2 Study comprised births at 26 completed weeks of gestation or lower in 
England during the calendar year of 2006.14 We undertook an evaluation of a sample of survivors at 
11 years of age using similar methodology to that used in the 11-year follow up of the EPICure study 
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cohort.13  Of 1041 EP survivors to discharge, invitations to take part in the 11-year assessment were 
sent to parents of 482 children admitted for care in 17 of the 45 NICUs and their networked 
hospitals operating in 200615, based on study centres in London and Leicester, respectively. The 
original EPICure population investigated outcomes for all children born in the UK and Ireland over 10 
months in 1995. For the purposes of this comparison we restricted participants to those born to 
women resident in England at the time, comprising 176 of the 219 children examined at 11 years. 
Study procedures Similar consent and evaluation processes were used in each study 13 (see 
Supplementary Appendix).  
Assessment procedure IQ was measured using the Kaufman Assessment Battery for Children (1995 
cohort: first edition; 2006: second edition) and academic attainment using the Wechsler Individual 
Achievement Test 2nd Edition (for details see Supplementary Appendix). Medical history was 
abstracted from parent-report questionnaires including the Gross Motor Function Classification 
System (GMFCS)16 and the Manual Abilities Classification System (MACS).17 Impairments were 
categorized in the same manner in both cohorts. Severe impairment comprised any one or more of 
an IQ score <-3 standard deviations of controls, cerebral palsy with GMFCS or MACS level 3-5, 
blindness or profound deafness; moderate impairment comprised any one or more of an IQ score <-
2SD to -3SD of controls, GMFCS or MACS level 2, visual impairment but not registered blind or 
wearing hearing aids but not with profound hearing loss. Children with less severe impairments or 
no functional limitations were categorized with no or mild impairment. The overall level of 
impairment was categorized by the most severe impairment for each child. WIAT-II scores were 
categorized as impairments using the SD banded categories derived using contemporary controls. 
Socio-economic status was determined by the Index of Multiple Deprivation (IMD) derived from 
small area indices of income, employment, education, health, crime, housing and the living 




Data processing Data were entered and managed using the REDCap electronic data capture tool18 
hosted at University College London and data were transferred and combined with the main EPICure 
Study dataset for analysis with STATA (Version 15.1; www.stata.com). All analyses were carried out 
within the UCL Data Safe Haven or performed on anonymized data. 
Analysis Because we had sampled the EPICure2 population, and to account for missing data, we 
performed regression and multiple imputation19 as sensitivity analyses to account for selective 
dropouts and missing information at 11 years when estimating major outcomes in children who 
were not assessed by the research team. Missing data were imputed by chained equations using the 
STATA “MI” procedure. Imputation model variables, percentages of missing values and models for 
predicting missing values are listed for both cohorts in Appendix Table S5. Imputation models were 
based on the missing at random assumption. Although five imputed datasets may be sufficient on 
theoretical grounds20, a larger number may reduce sampling variability from the imputation 
process.21 Twenty imputed datasets were created for this analysis.  
Study Permissions Approval was granted by both the UCL Research Ethics Committee (reference: 




Of the 482 invitees, families of 220 agreed to participate. Due to difficulties in scheduling 
assessments, we evaluated 200 of the 1031 EPICure2 children known to have been alive at 3 years at 
a mean age of 11.8 years (sd: 0.5y). This represented a 41% response rate and the sample comprised 
19% of the whole cohort; 112 were born ≤25 weeks of gestation, and therefore available to compare 
to outcomes from the 1995 cohort (Figure 1). From the original EPICure cohort of 219 participants 
evaluated at 11 years, 176 were born to women resident in England, 75% of the original population 
and examined at 10.9 (0.5) years. 
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Evaluation of dropouts Within each cohort, we compared the characteristics of dropouts with those 
assessed for births ≤25 weeks of gestation to women resident in England. We observed only small 
differences between perinatal characteristics, maternal age and IMD for the whole sample of English 
births ≤25 weeks of gestation and those evaluated in both cohorts (Table S1). In the 2006 cohort, the 
whole sample examined at 11 years, including those born at 26 weeks of gestation, was similar 
across a range of perinatal characteristics to the sample examined at 3 years of age. 
Neurodevelopmental impairment. In EPICure2, including births at 26 weeks of gestation, 36 
children (18%) had severe and 40 (20%) moderate impairment as defined above. Among the 
subgroup of children born before 26 weeks, 26% had severe impairment, 21% moderate and 53% 
no/mild impairment (Table 1; figure 2a). This compared to 18%, 32% and 49%, respectively, of births 
in England in EPICure. The relative risk ratio (RRR) of severe impairment in EPICure2 compared to 
EPICure was 1.34 (95%CI 0.73, 2.44) and for moderate impairment 0.62 (95%CI 0.35, 1.11). After 
adjustment for gestational age, birthweight z-score, male sex, multiple birth, maternal age and IMD 
at 11 years of age, RRRs were essentially unchanged. Combining the moderate and severe 
categories, the adjusted odds of neurodevelopmental impairment were 0.76 (96% CI 0.45, 1.31; 
P=.32).  
There were no significant differences in the frequency of motor or sensory impairments between 
the two cohorts, but there was a reduction in the proportion of children with moderate cognitive 
impairment in EPICure2 compared with EPICure, before and after adjustment for baseline 
characteristics and multiple testing. This was offset by an increase in children with severe 
impairment (Table 1). Combining moderate and severe categories reduced these differences further. 
Considering the rates of impairment at each gestational week, there were no significant differences 
between the two cohorts, although there was a trend both towards higher rates of impairment 
(Figure 2a) and higher prevalence of milder levels of functional motor impairment (Figure 2b) at 23 
weeks or below in EPICure2 (Table 2 & Table S2). 
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Cognitive scores Children in the control group had similar MPI scores in EPICure, using the KABC-I 
(mean 104; SD 11) to those in EPICure2 using the KABC-II (mean 103; SD 12; Table 2) and these were 
similar between the cohorts at each gestational week (Table S3). Using control group data as a 
contemporary reference to calculate z-scores in each cohort, there was a 1.9 SD (95% CI 1.6, 2.2) 
deficit for EP children versus controls in EPICure compared to a 1.8 SD (95% CI 1.4, 2.1) deficit in 
EPICure2; the difference in means of MPI z-scores between the two cohorts was 0.1 (95%CI -0.3, 0.5) 
points.  
Academic attainment In contrast to MPI scores, both the EP and control groups had higher WIAT-II 
reading and mathematics scores in EPICure2 compared to those in EPICure. However, using z-scores 
calculated from cohort-specific controls as the reference, there was a 1.5 SD (95%CI 1.9, 1.2) deficit 
in reading scores for EP children in EPICure compared to a 1.3 SD deficit (95% CI 1.7, 0.9) in 
EPICure2, giving an adjusted difference between cohorts in mean z-scores of 0.2 SD (95%CI -0.2, 0.7; 
P=.3). Results were similar for mathematics with an adjusted difference of 0.3 SD (95%CI 0.0, 0.7; 
P=.06) (Table 2 & Table S4). 
Overall there were no significant differences in the proportion of children with impaired reading or 
mathematics scores (P=.13 and P=.13, respectively) although there was a significantly reduced RRR 
for moderate reading impairment in EPICure2 compared to EPICure (0.32; 95%CI 0.11, 0.93) after 
adjustment for baseline differences. 
Results after multiple imputation There were small changes in both overall impairment rates and in 
the prevalence of cognitive impairment (Table 3). In particular the frequency of severe impairment 
was increased in the 2006 cohort, but with a corresponding fall in the moderate category, such that 






We report outcome at 11 years of age for the EPICure2 cohort of EP births in England in 2006. 
Outcome for babies born before 27 weeks of gestation is still attended by a significant risk of 
neurodevelopmental impairments, both in terms of deficits in IQ and academic attainment, and in 
motor impairment or cerebral palsy.  
In this analysis we compared outcomes for babies born 22-25 weeks of gestation in two cohorts of 
births 11 years apart. The prevalence of impairment in reading in EPICure2 appeared lower relative 
to those of the original EPICure study of births in 1995 but relating cognitive and educational scores 
to those of contemporary controls led to the conclusion that there are few differences. Therefore, 
we concluded that there were no significant changes in the prevalence of neurodevelopmental 
impairments or academic attainment over 11 years, despite over a decade of improvements in 
neonatal care; this has to be set alongside the significant improvements we have seen in survival 
and that have continued since. 
Comparing cohorts separated by 11 years has its challenges.  The cognitive test used in the first 
cohort had been superseded necessitating use of the 2nd edition of the test in the 2006 cohort. 
Differences in content between the two tests may have impacted on the results despite a similar 
theoretical construction. The same test of academic achievement was used in both cohorts making 
these data directly comparable, however scores had risen markedly in the 2006 cohort among both 
groups. This may be due to a phenomenon sometimes termed the Flynn effect22, whereby 
standardized population scores drift upwards over time, making it necessary to continually 
reappraise standardization data to produce contemporary normed scores. To counteract bias, we 
included standardized educational as well as cognitive tests to triangulate the differences observed 
and used contemporaneous classmate controls to examine deficits in both cohorts to account for 
any upward drift in test scores over time. Using these methods, we found few differences across 
standardised cognitive, reading or mathematics scores between the two cohorts. Both samples 
showed significant attrition and it seems unlikely that this occurs at random. In EPICure2 at 3 years 
of age, there was a higher dropout of families with social disadvantage4, as found in most studies23 24 
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but the dropout analysis for both studies shows good matching on baseline characteristics.  We used 
multiple imputation to account for other differences between the two populations but found 
essentially similar proportions with impairment in both cohorts.   
Other studies have found little change between cohorts of EP or VP births over time. Most studies 
do not report outcomes in middle childhood, reporting instead infant outcomes using 
developmental tests.  However the Victorian Infant Collaborative Study reported outcomes from 
three cohorts of EP (<28 weeks’ gestation)/ELBW infants born between 1991 and 2005 at eight years 
of age and concluded that moderate/severe impairment had not changed over the three cohorts, in 
contrast to their infant data at 2 years.25 Their data suggested even poorer educational outcomes, 
executive functions and motor performance at 8 years of age in EP/ELBW children born in 2005 
compared with those in the 1990s.7 26 Our data do not support this finding, instead identifying no 
discernible change in either IQ or academic attainment between EP children born <26 weeks of 
gestation in 2006 and 1995. 
Among more mature preterm infants, a meta-regression identified 71 studies of school age 
outcomes for very preterm populations (<32 weeks of gestation) and found no association between 
birth year and cognitive outcomes.8 The authors suggested that the major contributory factor was 
differences in BPD rates between studies. It is interesting that the rate of use of supplemental 
oxygen at 36 weeks, the most commonly used definition for “BPD” was very similar in both the 
EPICure cohorts.4  
We would have greater confidence if these national studies had achieved higher follow up rates. 
Following large cohorts of children scattered across the country is expensive and fraught with 
difficulty.  Routine clinical follow up to two years remains patchy in the UK27, despite being 
recommended for many years. Recent guidance recommends that routine outcome evaluation in 
the UK should include an IQ test at preschool age to provide a more robust measure for those born 
EP.28 An interesting option is to use nationally collected educational data which are considerably 
more consistent and complete and which have been shown to be associated with gestational age.29 
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These data may provide the opportunity to evaluate changing patterns of outcome robustly, as long 
as evaluation criteria remain the same.   
Difficulties in study retention and corresponding small sample sizes also make it difficult to explore 
interactions and sub-group analyses so it is possible that improvements are emerging among certain 
groups, but this is not affecting overall outcome. For example, it is possible that improvements in 
outcome have occurred among those from higher SES backgrounds with greater family resources, 
but such analyses are not possible in smaller datasets.  
Despite major advances in improved organization and delivery of neonatal care between 1995 and 
2006, and in survival, this has not yet been paralleled by improved investment in developmental 
follow-up or in educational support.30 If improving neonatal care is not resulting in the gains in 
neurodevelopmental outcomes once expected, then perhaps it is time to look at improving the 
provision of longer term developmental, parent and educational support31 32 as interventions to 
optimise long term outcomes. 
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Legends for Figures 
 
Figure 1: Derivation of the two samples of extremely preterm children at 11 years born in 
England in 1995 and 2006 
 
 
Figure 2 – Prevalence of categorization of overall impairment (a) and Gross Motor 
Function Classification System levels (b) by gestational age at birth at 11 years in the two 

















RRR (95% CI) 
P 
Adjusted* 
RRR (95% CI) 
P 
Overall Impairment     N=288  N=283  
  No/mild 49% (87/176) 53% (59/112) 0.85 - - - - 
  Moderate 32% (57/176) 21% (24/112)  0.62 (0.35,1.11) 0.11 0.58 (0.31,1.08) 0.08 
  Severe 18% (32/176) 26% (29/112)  1.34 (0.73,2.44) 0.35 1.14 (0.57,2.27) 0.71 
  Combined mod/severe 51% (89/176) 47% (53/112)  0.88 (0.55,1.41) 0.59 0.76 (0.45,1.31) 0.32 
Motor function         
  No CP or GMFCS /MACS 1 81% (143/176) 80% (90/112) 0.96 - - - - 
  GMFCS /MACS = 2 8.0% (14/176) 14% (16/112)  1.82 (0.85,3.90) 0.13 1.65 (0.71,3.82) 0.24 
  GMFCS /MACS 3-5 11% (19/176) 5% (6/112)  0.50 (0.19,1.30) 0.16 0.41 (0.14,1.16) 0.09 
  Combined mod/severe 19% (33/176) 20% (22/112)  1.06 (0.58,1.93) 0.85 0.93 (0.48,1.82) 0.84 
Cognitive Impairment        
  None (>-1SD) 30% (53/176) 37% (41/112) 0.80 - - - - 
  Mild (<-1 to -2 SD) 29% (51/176) 26% (29/112)  0.74 (0.40,1.35) 0.32 0.78 (0.40,1.48) 0.44 
  Moderate (<-2 to -3SD) 26% (45/176) 13% (14/112)  0.40 (0.19,0.83) 0.01 0.32 (0.15,0.70) 0.004 
  Severe (<-3SD) 15% (27/176) 25% (28/112)  1.34 (0.69,2.61) 0.39 1.16 (0.54,2.49) 0.70 
  Combined mod/severe 41% (72/176) 38% (42/112)  0.87 (0.53,1.41) 0.56 0.69 (0.40,1.18) 0.18 
Reading Impairment    N=279  N=276  
  None (>-1SD) 48% (82/171) 56% (60/108) 0.13 - - - - 
  Mild (<-1 to -2 SD) 19% (33/171) 23% (25/108)  1.04 (0.56,1.92) 0.91 1.01 (0.53,1.92) 0.99 
  Moderate (<-2 to -3SD) 12% (21/171) 5% (5/108)  0.33 (0.12,0.91) 0.03 0.32 (0.11,0.93) 0.04 
  Severe (<-3SD) 21% (35/171) 17% (18/108)  0.70 (0.36,1.36) 0.29 0.62 (0.30,1.27) 0.19 
  Combined mod/severe 33% (56/171) 21% (23/108)  0.56 (0.32,0.97) 0.04 0.51 (0.28,0.93) 0.03 
Maths Impairment    N=283  N=278  
  None (>-1SD) 28% (49/173) 36% (39/110) 0.13 - -   
  Mild (<-1 to -2 SD) 27% (46/173) 29% (32/110)  0.87 (0.47,1.62) 0.67 0.86 (0.45,1.65) 0.65 
  Moderate (<-2 to -3SD) 19% (33/173) 14% (15/110)  0.57 (0.27,1.20) 0.14 0.59 (0.27,1.29) 0.18 
  Severe (<-3SD) 26% (45/173) 22% (24/110)  0.67 (0.35,1.28) 0.23 0.57 (0.28,1.16) 0.12 
  Combined mod/severe 45% (78/173) 36% (39/110)  0.67 (0.41,1.09) 0.11 0.62 (0.36,1.07) 0.09 
Key: CP: cerebral palsy; GMFCS: Gross Motor Function Classification system; MACS: Manual Abilities Classification System; *Wilcoxon Rank Sum Test 
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 (n=176) (n=153) (n=112) (n=143) [c] v [a] [a] v [b] [c] v [d] (n=200) 
Kaufmann ABC 
scores 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) ∆ means 
(95%CI) 


























(-25, -18) ‡  
-21 
 (-25, -17) ** 
-22 
(-26, -18) ‡ 
-21 
(-25, -17) ‡ 
 85 (19) 
[n=200] 
            











(-2.3, -1.6) ‡  
-1.9  
(-2.2, -1.6) ‡ 
-1.8  
(-2.2, -1.5) ‡ 
-1.8  
(-2.1, -1.4) ‡ 




     
 
   
 













(-23, -16) ‡ 
-18  
(-22, -14) ‡ 
-15 
(-19, -11) ‡ 
-14  
(-19, -10) ‡ 
92 (21) 
[n=195] 
            










(-1.9, -1.3) ‡ 
-1.5  
(-1.9, -1.2) ‡ 
-1.4  
(-1.8, -1.0) ‡ 
-1.3  
(-1.7, -0.9) ‡ 
-1.0 (1.9) 
[n=195] 
            









(7.2, 18) ‡ 
14 
(7.9, 19) ‡ 
-28  
(-32, -24) ‡ 
-27  
(-32, -23) ‡ 
-26  
(-32, -21) ‡ 
-25  
(-31, -20) ‡ 
87 (27) 
[n=197] 
            











(-2.1, -1.6) ‡ 
-1.8  
(-2.1, -1.5) ‡ 
-1.6  
(-2.0, -1.3) ‡ 
-1.6  
(-1.9, -1.2) ‡ 
-1.4 (1.7) 
[n=197] 
* Multiple linear regression models were used to adjust for gestation, BW z score, male sex, multiple birth, maternal age and IMD at 11y. 
 Multiple linear regression models were used to adjust for male sex and IMD at 11y. 
† P=.001; ‡ P<0.001 
∆ Difference in means 







Table 3: Comparison of outcomes at 11 years for babies born at 22-25 weeks’ gestation in England in the two EPICure cohorts: results of 
imputation and a sensitivity analysis including maternal age at delivery in the imputation model (see Table 8 (Appendix) for variables and 
missingness). 
 













% (95%CI) % (95%CI) % (95%CI) % (95%CI) % (95%CI) 
  No/mild 49% (42, 57) 53% (43, 62) 45% (38, 52) 45% (39, 51) 44% (37, 50) 
  Moderate 32% (26, 40) 21% (15, 30) 34% (27, 41) 23% (18, 28) 24% (15, 33) 
  Severe 18% (13, 25) 26% (19, 35) 21% (15, 27) 32% (27, 37) 33% (24, 41) 
Cognitive disability      
  No/mild 59% (52, 66) 63% (53, 71) 53% (47, 60) 55% (48, 62) 55% (46, 64) 
  Moderate 26% (20, 33) 13% ( 8, 20) 28% (21, 34) 17% (10, 24) 17% ( 9, 24) 
  Severe 15% (11, 22) 25% (18, 34) 19% (13, 25) 28% (21, 35) 29% (22, 36) 
¶ 20 imputed datasets were used. *After adding maternal age at delivery in the imputation models 
 
